A Liverpool company that developed a surgical implant to cure lameness and restore mobility in dogs has “exceeded its targets” and secured a second six-figure investment from The North West Fund for Venture Capital.
The company’s patent protected technology allows it to create devices with interconnected solid and porous regions, providing strength where required and a bone interlock region. Bone cells can proliferate and mineralise in the porous structure to form a physiological bond between the host bone and the implant to enhance the performance and provide proprioception for the animal.
The company’s first product, an implant for use in canine knee reconstructions, is now widely used by veterinary practices throughout the UK.
Fusion Implants director Dan Jones said: “We are working closely with our veterinary surgeon customers to provide the next generation of animal implants. New products will include further knee implants to cater for other surgical problems, advances in surgical instrumentation to simplify the operative procedures and articular implants for specific breeds of dogs.”
The North West Fund’s initial investment in early 2014 helped finance the product launch – which included running training courses for vets and developing an app for use when planning operations – while this second sum will fund further research and development.
Lisa Ward of Enterprise Ventures, which manages The North West Fund for Venture Capital, said: “Fusion has exceeded its targets since the initial investment last year. This latest funding round will allow it to further develop its sales and distribution network and expand its product range.”